eval_parameters = [
    {"Manufacturing Capacity Utilization": "Closer to 100% utilization (to witness economies of scale and reduce cost per unit)"},
    {"Raw Material Source Reliability": "Analyze potential trade disruptions if raw material comes from sensitive locations (e.g., China)"},
    {"Management Future Plans": "A clean and clear thought process on future plans and strategies is preferred"},

    {"GDP Growth Rate (Annual)": "Check the specific rate and comparative performance (e.g., India growing faster than China)"},
    {"Labor Cost": "Check relative costs (e.g., labor cost in India was much lower than China)"},
    {"Macro Indicators": "Review unemployment rate, CRR, balance of trade, and current account to GDP percentage"},
    # {"Industry Growth Rate (CAGR)": "The overall industry should be performing well. Compare current growth rate to expected growth rate"},
    # {"Expected Industry Growth Rate": "Prefer expected growth rate to be higher than the current growth rate (e.g., Indian specialty chemical industry expected at 10.8% vs 9.8% previously)"},

    # {"Revenue, EBITDA, and Profit After Tax (PAT) Growth Rate": "Should ideally be higher than the industry growth rate (e.g., 24% company growth vs 14% industry growth)"},
    {"Debt to Equity Ratio": "A ratio up to 2:1 is generally considered okay"},
    {"Cash Flow from Operations (CFO)": "Must be positive and growing at a good rate"},

    # {"P/E Ratio (Price to Earning Ratio)": "Compare against listed peers; caution if the P/E is significantly higher (Use P/S ratio if the company is in losses)"},
    # {"Return on Net Worth (RONW)": "Compare against peers; higher RONW is preferable"},
    {"Comparable Transaction Multiple (CTM)": "IPO price should be justified if it is way higher than the price the company issued shares at recently"},
    # {"Gray Market Premium (GMP)": "Provides guidance: IPO Price + GMP = Expected Listing Price (not guaranteed)"},

    {"Type of Issue": "Prefer a Fresh Issue over a major Offer For Sale (OFS)"},
    {"Use of Proceeds": "Prefer funds used for expansion purpose over general corporate purpose"},
    {"Litigation/Investigation": "Be cautious if serious agencies like CBI or SFIO are investigating the promoters"},
    {"Customer Concentration": "Avoid when a small number of clients account for a high percentage of revenue (e.g., top 10 customers = 90%)"},
]

eval_questions = [
    {"Manufacturing Capacity Utilization": "What is the current utilization level of the company's manufacturing capacity (to witness economies of scale and reduce cost per unit)?"},

    {"Raw Material Source Reliability": "How reliable are the company's raw material sources, and are there potential trade disruptions due to sourcing from sensitive locations?"},

    {"Management Future Plans": "What are the company management's clearly stated future plans and strategies?"},

    {"GDP Growth Rate (Annual)": "What is the current GDP growth rate and how does it compare with other relevant economies?"},

    {"Labor Cost": "What is the comparative labor cost for the regions in which the company operates?"},

    {"Macro Indicators": "What do the key macro indicators — unemployment rate, CRR, balance of trade, and current account to GDP percentage—indicate about the economic environment?"},

    # {"Industry Growth Rate (CAGR)": "What is the current CAGR of the industry, and is the overall industry performing well compared to historical or expected growth?"},

    # {"Expected Industry Growth Rate": "What is the expected future industry growth rate, and is it higher than the current growth rate?"},

    # {"Revenue, EBITDA, and Profit After Tax (PAT) Growth Rate": "What are the company's Revenue, EBITDA, and PAT growth rates, and are they higher than the industry growth rate?"},

    {"Debt to Equity Ratio": "What is the company's current debt-to-equity ratio, and is it within the generally acceptable threshold of up to 2:1?"},

    {"Cash Flow from Operations (CFO)": "Is the company's cash flow from operations positive and growing at a healthy rate?"},

    # {"P/E Ratio (Price to Earning Ratio)": "How does the company's P/E ratio compare with listed peers, and is the valuation justified (or should P/S be used if the company is loss-making)?"},

    # {"Return on Net Worth (RONW)": "What is the company's Return on Net Worth, and how does it compare to peer companies?"},

    {"Comparable Transaction Multiple (CTM)": "Is the IPO price justified when compared with recent share issuance prices based on Comparable Transaction Multiples?"},

    # {"Gray Market Premium (GMP)": "What is the current Gray Market Premium (GMP), and what expected listing price does it imply (while noting it is not guaranteed)?"},

    {"Type of Issue": "Is the IPO structured as a Fresh Issue, an Offer For Sale (OFS), or a mix—and what is the proportion of each?"},

    {"Use of Proceeds": "How does the company intend to use the IPO proceeds, and what portion is allocated toward expansion versus general corporate purposes?"},

    {"Litigation/Investigation": "Are there any ongoing litigations or investigations involving the company or promoters, especially by serious agencies like CBI or SFIO?"},

    {"Customer Concentration": "What is the level of customer concentration, and do a small number of clients contribute disproportionately to revenue?"}
]
